Advanced breast cancer drug to become routinely available

A “landmark” deal has been announced on the breast cancer drug trastuzumab emtansine (Kadcyla), meaning that it can now be recommended for routine use by the NHS in England.
Source: Nursing Times - Category: Nursing Source Type: news